Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer

BACKGROUND: DNA damage and DNA damage repair (DDR) are important therapeutic targets for triple-negative breast cancer (TNBC), a subtype with limited chemotherapy efficiency and poor outcome. However, the role of microRNAs in the therapy is emerging. In this study, we explored whether miR-26a-5p cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Lv, Lianqiu, Zheng, Renjing, Xie, Rong, Yu, Yuanhang, Liao, Han, Chen, Jianying, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294332/
https://www.ncbi.nlm.nih.gov/pubmed/37365643
http://dx.doi.org/10.1186/s13058-023-01663-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294332/
https://www.ncbi.nlm.nih.gov/pubmed/37365643
http://dx.doi.org/10.1186/s13058-023-01663-y

Ejemplares similares